2,2,2-Trifluoroethyl N-(4-tert-butylphenyl)carbamate

Catalog No.: 
ACMTDS682
CAS No.: 
1087789-00-1
Molecular Formula: 
C13H16F3NO2
Molecular Weight: 
275.27
2,2,2-Trifluoroethyl N-(4-tert-butylphenyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$117.00InquiryInquiry
100mg95%$164.00InquiryInquiry
250mg95%$226.00InquiryInquiry
1g95%$552.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,2,2-Trifluoroethyl N-(4-tert-butylphenyl)carbamate
IUPAC Name2,2,2-trifluoroethyl (4-(tert-butyl)phenyl)carbamate
MDL No.MFCD11099875
Molecular FormulaC13H16F3NO2
Molecular Weight275.27
SMILESO=C(OCC(F)(F)F)NC1=CC=C(C(C)(C)C)C=C1
InChI KeyATNHESAJBLNPDA-UHFFFAOYSA-N
Synonym2,2,2-Trifluoroethyl N-(4-tert-Butylphenyl)carbamate;Carbamic acid, N-[4-(1,1-dimethylethyl)phenyl]-, 2,2,2-trifluoroethyl ester
CAS No.1087789-00-1

Synthetic Route by SureRoute

1. ACMTDS682 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAMJD952 route compound structure diagram
    ACAMJD952769-92-6In Stock
  2. Plus
  3. ACCDJG914 route compound structure diagram
    ACCDJG91427746-99-2In Stock
  4. Then
  5. ACMTDS682 route product structure diagram
    ACMTDS6821087789-00-1
Inquiry

2. ACMTDS682 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAMZJ746 route compound structure diagram
    ACAMZJ7461943-67-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMTDS682 route product structure diagram
    ACMTDS6821087789-00-1
Inquiry

3. ACMTDS682 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAMJD952 route compound structure diagram
    ACAMJD952769-92-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMTDS682 route product structure diagram
    ACMTDS6821087789-00-1
Inquiry

Comments (0)